Stringent Regulations to Contain the Hospital Acquired Disease

Non-PVC IV bags are designed for parenteral nutrition, containing rehydration solutions such as sodium chloride, glucose, ringer lactate, and hospital-specific antibiotics and analgesics. In addition, different solutions can be used for the collection of donor blood sources. PVC-free IV bags are known for their safety and convenience in handling and transporting. These bags are in great demand in the treatment of cancer. Some of the drugs used in these treatments tend to interact with compounds found in traditional PVC IV containers and tend to turn into dangerous drugs.

Growth Factors for Non-PVC IV Bags Market

The growing number of point-of-care facilities and home care settings is driving up demand for single-chamber bags, which will benefit the overall market. Non-PVC substitute demand is expected to rise in response to rising global requirements for nontoxic medical packaging and increasing enforcement for stringent legislation prohibiting the use of PVC. Significant R&D for new alternatives is also expected to drive the global market during the forecast period. Some of the primary market drivers are the growing demand for preventive measures to reduce errors, such as incorrect dose delivery, and increasing preference for innovative IV containers.

Parenteral nutrition and chemotherapy are two of the most common applications for non-PVC IV bags. PVC packaging is likely to be replaced by non-PVC substitutes such as polypropylene and EVA with the advent of various substitutes such as EVA and polypropylene. These materials can be used for a variety of applications, including cold or frozen storage and custom mixtures. Furthermore, technological advancements in providing quality services, as well as an increase in the number of hospitals worldwide, are a few of the factors driving the growth of the Non-PVC IV bags market.

COVID-19 Outbreak Influence on Non-PVC IV Bags Market

COVID-19 is expected to have a positive impact on global market growth during the forecast period. Many COVID-19-infected patients require hospitalization, where bags are used to deliver medications and nutrition to patients, which is expected to drive the growth of the non-PVC bag market.

North America to Dominate the Non-PVC IV Bags Market

North America is the dominant region, with a large number of players launching newer developments aimed at bringing in more efficient IV bags. Rising government initiatives, rising R&D expenditure, rising disease prevalence, established healthcare infrastructure, and the presence of several major players are all working in the market's favor. The United States controls the largest share of the Non-PVC IV Bags Market in North America.

Furthermore, the rising adoption of novel drug delivery systems, as well as technological advancements, are expected to drive the non-PVC IV bags market in this region. Asia Pacific is expected to be the fastest-growing regional market in the coming years. Rapid advancements in healthcare infrastructure, including a rise in the number of hospitals and blood banks coupled with increasing foreign direct investment, are driving the industry's expansion.

Deep-dive Insights on Non-PVC IV Bags Market by Polaris Market Research: https://www.polarismarketresearch.com/industry-analysis/non-pvc-iv-bags-market/request-for-sample